See also this year's filing and all EDGAR filings for this company.
PDF Report 0001270073_2018_INTERCEPT_PHARMACEUTICALS_INC.pdf
Logs
Graph
Absolute values for 0001270073, INTERCEPT PHARMACEUTICALS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 448,307,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 16,184,000 |
| 3 | remainder_Assets | 19,856,000 |
| 4 | LiabilitiesCurrent | 104,034,000 |
| 5 | LiabilitiesNoncurrent | 361,255,000 |
| 6 | remainder_Liabilities | 2,672,000 |
| 7 | CostOfGoodsAndServicesSold | 1,371,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 273,698,000 |
| 9 | ResearchAndDevelopmentExpense | 191,499,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 130,956,000 |
| 12 | remainder_NetIncome | -24,755,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 484,347,000 |
| 1 | Liabilities | 467,961,000 |
| 2 | Expenses | 466,568,000 |
| 3 | Revenues | 130,956,000 |
| 4 | StockholdersEquity | 16,386,000 |
| 5 | NetIncome | -360,367,000 |
| 6 | ComprehensiveNetIncome | -360,367,000 |
| 7 | BaseVar | 787,293,500 |
| 8 | EconomicCapitalRatio | -0.698 |
Edgar->Model Mapping
Feature Distribution
Change over Time
